Treatment and survival disparities in lung cancer: the effect of social environment and place of residence
- PMID: 24491311
- DOI: 10.1016/j.lungcan.2014.01.008
Treatment and survival disparities in lung cancer: the effect of social environment and place of residence
Abstract
Objective: The purpose of this study was to measure the extent to which geographic residency status and the social environment are associated with disease stage at diagnosis, receipt of treatment, and five-year survival for patients diagnosed with non-small cell lung cancer (NSCLC).
Methods and materials: This study was a retrospective cohort study of the Georgia Comprehensive Cancer Registry (GCCR) for incident cases of NSCLC diagnosed in the state. Multilevel logistic models were employed for five outcome variables: unstaged and late stage disease at diagnosis; receipt of treatment (surgery, chemotherapy, and radiation); and survival following diagnosis. The social and geographical variables of interest were census tract (CT) poverty level, CT-level educational attainment, and CT-level geographic residency status.
Results: Compared to urban residents, rural and suburban residents had increased odds of unstaged disease (suburban OR=1.23, 95% CI: 1.11-1.37; rural OR=1.63, 95% CI: 1.45-1.83). In this study, rural participants had lower odds of receiving radiotherapy (OR=0.89, 95% CI: 0.82-0.96) and chemotherapy (OR=0.92, 95% CI: 0.85-0.99). Living in CTs with lower educational levels was associated with decreasing odds of receiving both surgery (lowest educational level OR=0.67, 95% CI: 0.59-0.75) and chemotherapy (lowest educational level OR=0.74, 95% CI: 0.68-0.81). Living in areas with higher concentration of deprivation (high level of deprivation HR=1.04, 95% CI: 1.01-1.09) and lower levels of education (lowest educational level HR=1.12, 95% CI: 1.07-1.17) was associated with poorer survival. Rural residents did not show poorer survival when treatment was controlled and they even presented a lower risk of death for early stage disease (HR=0.90, 95% CI: 0.82-0.99).
Conclusion: This study concludes that where NSCLC patients live can, to some extent, explain treatment and prognostic disparities. Public health practitioners and policy makers should be cognizant of the importance of where people live and shift their efforts to improve lung cancer outcomes in rural areas and neighborhoods with concentrated poverty.
Keywords: Disparity; Lung cancer; Place; Place of residence; Poverty; Rurality; Social environment; Survival; Treatment.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Neighborhood context and non-small cell lung cancer outcomes in Florida non-elderly patients by race/ethnicity.Lung Cancer. 2020 Apr;142:20-27. doi: 10.1016/j.lungcan.2020.01.012. Epub 2020 Jan 16. Lung Cancer. 2020. PMID: 32062478
-
The Effects of Residential Segregation and Neighborhood Characteristics on Surgery and Survival in Patients with Early-Stage Non-Small Cell Lung Cancer.Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):750-8. doi: 10.1158/1055-9965.EPI-15-1126. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27197137
-
Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States.Cancer. 2012 Oct 15;118(20):5117-23. doi: 10.1002/cncr.26185. Epub 2012 Mar 5. Cancer. 2012. PMID: 22392287
-
Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Arch Phys Med Rehabil. 2008. PMID: 18373987 Review.
-
A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.Eur J Surg Oncol. 2014 Mar;40(3):311-7. doi: 10.1016/j.ejso.2013.11.012. Epub 2013 Dec 4. Eur J Surg Oncol. 2014. PMID: 24332948 Review.
Cited by
-
The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer.Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1498-1505. doi: 10.1158/1055-9965.EPI-20-1555. Epub 2021 Jun 4. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34088750 Free PMC article.
-
Socioeconomic Differences and Lung Cancer Survival-Systematic Review and Meta-Analysis.Front Oncol. 2018 Nov 27;8:536. doi: 10.3389/fonc.2018.00536. eCollection 2018. Front Oncol. 2018. PMID: 30542641 Free PMC article.
-
Survival Disparities in the Radiotherapeutic Management of Lung Cancer by Regional Poverty Level.Cureus. 2018 Nov 12;10(11):e3575. doi: 10.7759/cureus.3575. Cureus. 2018. PMID: 30656079 Free PMC article.
-
Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.Ann Surg Oncol. 2022 Jun;29(6):3630-3639. doi: 10.1245/s10434-021-11160-1. Epub 2022 Jan 7. Ann Surg Oncol. 2022. PMID: 34997420
-
Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.J Thorac Cardiovasc Surg. 2020 Jul;160(1):261-271.e1. doi: 10.1016/j.jtcvs.2019.10.102. Epub 2019 Nov 13. J Thorac Cardiovasc Surg. 2020. PMID: 31924363 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials